首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Simultaneous, quantitative determination of opiates, amphetamines, cocaine and benzolyecgonine in oral fluid by liquid chromatography quadrupole-time-of-flight mass spectrometry
【24h】

Simultaneous, quantitative determination of opiates, amphetamines, cocaine and benzolyecgonine in oral fluid by liquid chromatography quadrupole-time-of-flight mass spectrometry

机译:液相色谱四极杆飞行时间质谱同时定量测定口腔液中的鸦片,安非他明,可卡因和苯甲酰吗啡

获取原文
获取原文并翻译 | 示例
       

摘要

A method using liquid chromatography coupled to tandem mass spectrometry is described for the determination of drugs of abuse in oral fluid. The method is able to simultaneously quantify amphetamines (amphetamine, methamphetamine, MDA, MDMA and MDEA), opiates (morphine and codeine), cocaine and benzolyecgonine. Only 200 μl of oral fluid is spent for analysis. The sample preparation is easy and consists of mixed mode phase solid-phase extraction. Reversed-phase chromatography is carried out on a narrow bore phenyl type column at a flow-rate of 0.2 ml/min. A gradient is applied ranging from 6 to 67.6% methanol with ammonium formate (10 mM, pH 5.0) added to the mobile phase. The column effluent was directed into a quadrupole-time-of-flight instrument by electrospray ionization, without the use of a splitter. A validation study was carried out. Recovery ranged from 52.3 to 98.8%, within-day and between-day precision expressed by relative standard deviation were less than 11.9 and 16.8%, respectively, and inaccuracy did not exceed 11.6%. The limit of quantification was 2 ng/ml (0.66 * 10~(-5)-1.48 * 10~(-5) M) for all compounds. Internal standards were used to generate quadratic calibration curves (r~12>0.999). The method was applied to real samples obtained from suspected drug users. An interference was observed from the device used to sample the oral fluid, consequently this was excluded from the method which was validated on oral fluid obtained by spitting in a test-tube.
机译:描述了一种使用液相色谱与串联质谱联用的方法,用于确定口服液中的滥用药物。该方法能够同时定量安非他命(安非他明,甲基苯丙胺,MDA,MDMA和MDEA),鸦片制剂(吗啡和可待因),可卡因和苯并乙氨酸。仅200μl的口腔液用于分析。样品制备简单,由混合模式固相萃取组成。反相色谱法是在窄口径的苯基型色谱柱上以0.2 ml / min的流速进行的。施加6-67.6%甲醇的梯度,并向流动相中添加甲酸铵(10 mM,pH 5.0)。无需使用分流器,通过电喷雾电离将色谱柱流出物导入四极杆飞行时间仪器中。进行了验证研究。回收率介于52.3%至98.8%之间,以相对标准偏差表示的日内和日间精度分别小于11.9和16.8%,并且不准确度不超过11​​.6%。所有化合物的定量限均为2 ng / ml(0.66 * 10〜(-5)-1.48 * 10〜(-5)M)。内标用于生成二次校准曲线(r〜12> 0.999)。该方法适用于从可疑吸毒者那里获得的真实样品。从用于采样口腔液的设备中观察到干扰,因此,该方法排除了该方法,该方法已通过在试管中吐痰获得的口腔液进行了验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号